Study: Genetic makeup hints at antidepressant response

07/20/2008 | Forbes

White patients with two mutations in the serotonin transporter gene, SLC6A4, are more likely to benefit from antidepressant Celexa, according to a U.S. study of about 2,000 people. The research found no association between the variations and chances of remission in black or Hispanic patients. "The findings of this study represent another step in advancing individualized medicine for psychiatric patients," the lead author said.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX